Please login to the form below

Not currently logged in
Email:
Password:

Gliadel

This page shows the latest Gliadel news and features for those working in and with pharma, biotech and healthcare.

Glioblastomas - a personalised future?

Glioblastomas - a personalised future?

Even agents approved within the last decade - a wafer formulation of carmustine (Gliadel) for implantation into the post-surgical tumour cavity and temozolomide (Temodal), an oral imidazotetrazine derivative of the alkylating

Latest news

  • Early 2013 sees drug filings, launches and approvals in Japan Early 2013 sees drug filings, launches and approvals in Japan

    Eisai and Nobelpharma have launched brain cancer drug Gliadel (carmustine), which becomes the only sustained-release formulation approved for intracranial implantation in Japan. ... Nobelpharma acquired manufacturing and marketing rights to Gliadel from

  • Back on track

    Gliadel wafers are implanted in the tumour cavity created in the brain after surgical removal and release carmustine slowly, directly to the tumour site. ... Gliadel has been shown to prolong the survival of patients significantly compared with those

  • New accounts: October

    Dermatology. Life. Link Pharmaceuticals. Gliadel implant. Oncology. Addjuice. Napp Pharmaceuticals. New product.

  • New accounts: November

    Pulsar Healthcare Communications. Link Pharmaceuticals. Gliadel implant. Oncology. Addjuice. Mayne Pharma.

  • New accounts: August

    Janssen-Cilag. Lyrinel XL. Urinary incontinence. PBC Communications. Link Pharmaceuticals. Gliadel implant.

More from news
Approximately 1 fully matching, plus 13 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....